Metachronous Multiple Primary Inoperable Squamous Cancer of the Esophagus: Case Report

Author:

Gladilina I. A.1ORCID,Chernykh M. V.2ORCID,Ishchanov D. G.2ORCID,Sukhova E. A.3,Abu-Haidar O. B.2ORCID,Tryakin A. A.2,Ryabova V. E.2ORCID,Lebedenko I. M.4ORCID,Tulin P. E.2ORCID,Ivanov S. M.2ORCID

Affiliation:

1. N.N. Blokhin National Medical Research Center of Oncology; Russian National Research Medical University

2. N.N. Blokhin National Medical Research Center of Oncology

3. Russian National Research Medical University

4. N.N. Blokhin National Medical Research Center of Oncology; National Research Nuclear University MEPhI

Abstract

The incidence of primary multiple malignant neoplasms (PMMN) in Russia is steadily increasing due to the increasing frequency of detection of metachronous tumors. A similar trend is observed in esophageal cancer (EC). Advances in the diagnosis and treatment of cancer have led to an increase in the life expectancy of patients after a cured primary tumor and, in turn, to an increase in the detection rate of a second tumor. The longer life expectancy of patients with cancer, the higher the likelihood of developing a second tumor. PMMN of the esophagus is one of the least studied problems in modern oncology, which complicates the choice of treatment tactics, since there are no standards for the management of such patients. This article reflects a multidisciplinary and individual approach to the treatment of a patient with primary multiple metachronous inoperable squamous cell carcinoma of the middle and lower thoracic esophagus. The patient underwent chemoradiotherapy (CRT) with full effect, with no post-radiation damage and improved quality of life.

Publisher

Non-profit partnership Society of Interventional Oncoradiologists

Reference16 articles.

1. Morgan E, Soerjomataram I, Rumgay H, et al. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 2022 Sep;163(3):649-58.e2. https://doi.org/10.1053/j.gastro.2022.05.054. Epub 2022 Jun 4. PMID: 35671803.

2. World Health Organization. Oesophagus. Accessed January 13, 2023. Available at: http://gco.iarc.fr/today/data/factsheets/cancers/6-Oesophagus-fact-sheet.pdf

3. Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17-48. https://doi.org/10.3322/caac.21763

4. Kaprin AD, Starinsky VV. The state of oncological care to the population of Russia in 2021. 2022; 60 p. (In Russ.).

5. Dvoretskiy SYu. Modern treatment strategy esophageal cancer. I.I. Greeks Bulletin of Surgery. 2016;175(4):102-7. (In Russ.)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3